Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMT5AEF)

Drug Name

TST-10088 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Ribosome (hRBS)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
ELX-02	DMK3C4L	Cystic fibrosis	CA25	Phase 2	[3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Ribosome (hRBS)	TTJ073B	NOUNIPROTAC	Immunomodulator (Immunostimulant)	[2]

------------------------------------------------------------------------------------

References

1	AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics-Oct 22-26, 2007, San Francisco, CA.
2	Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2009 Nov;31(9):597-633.
3	A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of ELX-02 in Healthy Subjects. Clin Pharmacol Drug Dev. 2021 Aug;10(8):859-869.